| Abused Drugs/Toxicology |
| Acetaminophen |
| Amphetamine/ Methamphetamine II |
| Barbiturates II U |
| Benzodiazepines |
| Cannabinoids |
| Cocaine Metabolite |
| Methadone |
| Opiates |
| Phencyclidine II |
| REA Ethanol |
| Salicylate |
| Tricyclic Antidepressants |
| |
| Cancer |
| AFP |
| CA 125 (Trademark of Fujirebio Diagnostic Inc.) |
| CA 15-3 (Trademark of Fujirebio Diagnostic Inc.) |
| CEA |
| PSA |
| |
| Fertility/Pregnancy |
| Estradiol |
| FSH |
| LH |
| Prolactin |
| Total B-hCG |
| |
| Fertility/Pregnancy-Congenital Diseases |
| CMV IgM |
| Rubella IgG 2.0 |
| Rubella IgM |
| TOXO IgG 2.0 |
| TOXO IgM |
| |
| Heart Disease |
BNP
(The AxSYM Plus BNP assay is currently in development.
CK-MB) |
| Myoglobin |
| Troponin-I |
| |
|
| Metabolic |
Cortisol
(The AxSYM Plus Cortisol assay is in development in the United States.) |
| Homocysteine |
PTH
(The AxSYM Plus PTH assay is in development in the United States.) |
| |
| Therapeutic Drug Monitoring |
| Carbamazepine |
| Digoxin II |
| Gentamicin |
| N-Acetylprocainamide |
| Phenobarbital |
| Phenytoin |
| Procainamide |
| Quinidine |
| Theophylline II |
| Tobramycin |
| Valproic Acid |
| Vancomycin II |
| |
| Thyroid |
Anti-Tg
(The AxSYM Plus Anti-Tg assay is in development in the United States.) |
Anti-TPO
(The AxSYM Plus Anti-TPO assay is in development in the United States.) |
| Free T3 |
| Free T4 |
| Total T3 |
| Total T4 |
| T-Uptake |
| Ultrasensitive hTSH II |
| |
|
